Sotorasib in KRAS G12C-mutated NSCLC: A multicenter real-world experience from the expanded access program in Germany

被引：2

作者：

Althoff, F. C. ^{[1
]}

Stratmann, J. A. ^{[1
]}

Doebel, P. ^{[1
]}

Hunerlituerkoglu, A. N. ^{[2
]}

Frost, N. ^{[3
,4
]}

Christopoulos, P. ^{[5
]}

Zum Bueschenfelde, C. Meyer ^{[6
]}

Alt, J. ^{[7
]}

Webendoerfer, M. ^{[8
]}

Kaldune, S. ^{[9
]}

Tritchkova, G. ^{[10
]}

Waller, C. F. ^{[11
]}

Braess, J. ^{[12
]}

Kopp, H-G. ^{[13
]}

Grohe, C. ^{[14
]}

Schumann, C. ^{[15
]}

Griesinger, F. ^{[16
]}

Kuon, J. B. ^{[17
]}

Sebastian, M.

Reinmuth, N. ^{[18
]}

机构：

[1] Johannes Wolfgang Goethe Univ, Haematol Oncol, Univ Klinikum Frankfurt, Frankfurt, Germany

[2] Helios Klinikum Krefeld, Hematol Oncol, Krefeld, Germany

[3] Univ Klin, Dept Infect Dis & Pneumonol, Berlin, Germany

[4] Charite Campus Virchow Klinikum, Berlin, Germany

[5] Thoraxklin Heidelberg gGmbH, Dept Oncol Thorac Tumors, Heidelberg, Germany

[6] ViDia Karlsruhe Diakonissenkrankenhaus, Hematol Oncol, Karlsruhe, Germany

[7] Univ Med Mainz, Med Klin Poliklin 3, Mainz, Germany

[8] Univ Klinikum Essen, Med Oncol, Essen, Germany

[9] RoMed Klinikum Rosenheim, Med Klin, Rosenheim, Germany

[10] Tech Univ Dresden, Internal Med, Carl Gustav Carus Fac Med, Dresden, Germany

[11] Univ Klinikum Freiburg, Hematol Oncol & Stem Cell Transplantat, Klin Innere Med Hamatol Onkol & Stammzelltranspla, Freiburg, Germany

[12] St John Gods Hosp, Hematol Med Oncol, Regensburg, Germany

[13] Robert Bosch Kran Kenhaus, Dept Hematol Oncol, Stuttgart, Germany

[14] ELK Berlin Chest Hosp, Pneumol, Evangel Lungenklin, Berlin, Germany

[15] Klinikum Kempten Oberallgaeu gGmbH, Klin Pneumol Thoraxonkol Schlaf & Beamtungsmed, Kempten, Germany

[16] Pius Hosp, Dept Oncol, Oldenburg, Germany

[17] SLK Kliniken Heilbronn GmbH, Thorac Oncol Dept, Heilbronn, Germany

[18] Asklepios Fachklinikum, Thorac Oncol, Gauting, Germany

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.2437

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1405P

引用

页数：1

共 50 条

[1] Sotorasib in KRAS G12C-Mutated Non-Small Cell Lung Cancer: A Multicenter Real-World Experience from the Expanded Access Program in Germany
Althoff, F. C.
Stratmann, J. A.
Doebel, P.
Rauh, J.
Trummer, A.
Huenerlituerkoglu, A. N.
Frost, N.
Yildirim, H.
Christopoulos, P.
Burkhard, O.
zum Bueschenfelde, Meyer C.
von Rose, Becker A.
Alt, J.
Aries, S. P.
Webendoerfer, M.
Kaldune, S.
Uhlenbruch, M.
Tritchkova, G.
Waller, C. F.
Rittmeyer, A.
Hoffknecht, P.
Braess, J.
Kopp, H. G.
Grohe, C.
Schaefer, M.
Schumann, C.
Griesinger, F.
Kuon, J.
Sebastian, M.
Reinmuth, N.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 145 - 146
[2] Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany
Stratmann, Jan A.
Althoff, Friederike C.
Doebel, Paula
Rauh, Jacqueline
Trummer, Arne
Huenerlituerkoglu, Ali Nuri
Frost, Nikolaj
Yildirim, Huesameddin
Christopoulos, Petros
Burkhard, Oswald
Bueschenfelde, Christian Meyer zum
von Rose, Aaron Becker
Alt, Juergen
Aries, Sven P.
Webendoerfer, Maximilian
Kaldune, Stefan
Uhlenbruch, Mark
Tritchkova, Guergana
Waller, Cornelius F.
Rittmeyer, Achim
Hoffknecht, Petra
Braess, Jan
Koppu, Hans-Georg
Grohe, Christian
Schaefer, Monica
Schumann, Christian
Griesinger, Frank
Kuon, Jonas
Sebastian, Martin
Reinmuth, Niels
EUROPEAN JOURNAL OF CANCER, 2024, 201
[3] Impact of Sotorasib and Adagrasib in KRAS G12C-Mutated NSCLC
Patel, Sandip P.
ONCOLOGY-NEW YORK, 2023, 37 (12): : 479 - 479
[4] Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program
Passiglia, Francesco
Reale, Maria Lucia
Lo Russo, Giuseppe
Pasello, Giulia
Minuti, Gabriele
Bulotta, Alessandra
Galetta, Domenico
Pelizzari, Giacomo
Sini, Claudio
Bria, Emilio
Roca, Elisa
Pilotto, Sara
Genova, Carlo
Metro, Giulio
Citarella, Fabrizio
Chiari, Rita
Cortinovis, Diego
Delmonte, Angelo
Russo, Alessandro
Tiseo, Marcello
Cerea, Giulio
Carta, Annamaria
Scotti, Vieri
Vavala, Tiziana
Brambilla, Marta
Buffoni, Lucio
Buosi, Roberta
Catania, Chiara
Gori, Stefania
Grisanti, Salvatore
Agustoni, Francesco
Garbo, Edoardo
Malapelle, Umberto
Novello, Silvia
LUNG CANCER, 2024, 187
[5] Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C-Mutated NSCLC
Zhou, Katherine I.
Lin, Chenyu
Tseng, Chin-Lin
Ramnath, Nithya
Dowell, Jonathan E.
Kelley, Michael J.
JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (05):
[6] Assessing the safety profile of sotorasib in KRAS G12C-mutated advanced NSCLC
Reactions Weekly, 2025, 2045 (1) : 6 - 6
[7] FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC
Nakajima, Erica C.
Drezner, Nicole
Li, Xiaoxue
Mishra-Kalyani, Pallavi S.
Liu, Yajun
Zhao, Hong
Bi, Youwei
Liu, Jiang
Rahman, Atiqur
Wearne, Emily
Ojofeitimi, Idara
Hotaki, Lauren Tesh
Spillman, Dianne
Pazdur, Richard
Beaver, Julia A.
Singh, Harpreet
CLINICAL CANCER RESEARCH, 2022, 28 (08) : 1482 - 1486
[8] Sotorasib in KRAS p.G12C mutated advanced NSCLC: Real-word data from the Italian Expanded Access Program
Reale, M. L.
Passiglia, F.
Brambilla, M.
Pasello, G.
Minuti, G.
Bulotta, A.
Pizzutilo, P.
Sini, C.
Costa, J.
Roca, E.
Bria, E.
Pilotto, S.
Genova, C.
Metro, G.
Citarella, F.
Bordi, P.
Russo, A.
Chiari, R.
Andrikou, K.
Novello, S.
ANNALS OF ONCOLOGY, 2023, 34
[9] CodeBreaK 101: Safety and Efficacy of Sotorasib with Carboplatin and Pemetrexed in KRAS G12C-Mutated Advanced NSCLC
Clarke, J. M.
Felip, E.
Li, B. T.
Ruffinelli, J. C.
Garrido, P.
Zugazagoitia, J.
Goldberg, S. B.
Ramalingam, S. S.
Victoria, I.
Puri, S.
Gandara, D. R.
Varrieur, T.
Edmonds, S.
Palmer, K.
Snyder, W.
Govindan, R.
Rybkin, I.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S118 - S119
[10] Sotorasib in KRAS p.G12C-mutated NSCLC
Gassa, Asmae
Oezkan, Filiz
Bruns, Christiane
Schmidt, Thomas
Alakus, Hakan
ONKOLOGE, 2021, 27 (10): : 1031 - 1032

← 1 2 3 4 5 →